A new study reveals that many perceived benefits of gluten-free products, such as weight control and diabetes management, are ...

Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.

The prevalence of irritable bowel syndrome and chronic idiopathic constipation rose significantly during the COVID-19 pandemic.

Incidental BE was common and associated with high-risk features that were similar to or more severe than those found in BE diagnosed by traditional methods.

HealthDay News — The viability of hospital-based emergency care in the United States is at risk, according to a RAND report released April 7.

Hormone diets have taken off on social media as the latest weight loss trend, but their scientific validity remains ...

Adverse pregnancy outcomes mediate a small proportion of the association between prepregnancy obesity and CVD risk in midlife.

Overall cancer mortality rates declined from 2001-2022; cancer incidence rates decreased from 2001-2013 and stabilized through 2021.

The Trump administration is weighing a plan to cut nearly a third of the federal health budget and eliminate dozens of programs.

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

From 2000 to 2021, there was an increase in the incidence of pancreatic adenocarcinoma, which was seen in all age groups.

The FDA has approved a tablet form of Livmarli (maralixibat) for cholestatic pruritus in patients with Alagille syndrome and progressive familial intrahepatic cholestasis.